The Accelerating Medicines Partnership between the National Institutes of Health, U.S. Food and Drug Administration and private-sector partners has launched a big data portal for the sharing and analysis of research on Alzheimer’s
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.